Form 8-K - Current report:
SEC Accession No. 0001493152-24-037953
Filing Date
2024-09-24
Accepted
2024-09-24 16:05:38
Documents
20
Period of Report
2024-09-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44690
2 ex3-1.htm EX-3.1 1997
3 ex99-1.htm EX-99.1 13281
4 ex3-1_001.jpg GRAPHIC 146914
5 ex3-1_002.jpg GRAPHIC 317054
6 ex99-1_001.jpg GRAPHIC 13023
7 ex99-2.htm EX-99.2 17090
8 ex99-2_001.jpg GRAPHIC 14564
  Complete submission text file 0001493152-24-037953.txt   947289

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE meds-20240920.xsd EX-101.SCH 3009
10 XBRL LABEL FILE meds-20240920_lab.xml EX-101.LAB 34916
11 XBRL PRESENTATION FILE meds-20240920_pre.xml EX-101.PRE 24591
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4087
Mailing Address 2420 BRUNELLO TRACE LUTZ FL 33558
Business Address 2420 BRUNELLO TRACE LUTZ FL 33558 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39199 | Film No.: 241320245
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)